Charles River Laboratories
CRL
#1960
Rank
NZ$18.13 B
Marketcap
NZ$376.47
Share price
-0.14%
Change (1 day)
50.80%
Change (1 year)
Categories

Earnings for Charles River Laboratories (CRL)

Earnings in 2026 (TTM): -NZ$0.3 Billion

According to Charles River Laboratories 's latest financial reports the company's current earnings are NZ$4.02 Billion. In 2025 the company made an earning of -NZ$0.18 Billion a decrease over its 2024 earnings that were of NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Charles River Laboratories from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.3 Billion71.11%
2025 -NZ$0.18 Billion-206.86%
2024 NZ$0.15 B-83.98%
2023 NZ$0.99 B-6.69%
2022 NZ$1.06 B29.6%
2021 NZ$0.82 B7.51%
2020 NZ$0.76 B47.04%
2019 NZ$0.52 B7.95%
2018 NZ$0.48 B-5.14%
2017 NZ$0.50 B33.21%
2016 NZ$0.38 B14.07%
2015 NZ$0.33 B10.04%
2014 NZ$0.30 B28.39%
2013 NZ$0.23 B6.61%
2012 NZ$0.22 B-2.2%
2011 NZ$0.22 B-140.16%
2010 -NZ$0.57 Billion-321.56%
2009 NZ$0.25 B-131.92%
2008 -NZ$0.81 Billion-314.85%
2007 NZ$0.37 B23.14%
2006 NZ$0.30 B10.82%
2005 NZ$0.27 B4.46%
2004 NZ$0.26 B15%
2003 NZ$0.22 B15.93%
2002 NZ$0.19 B64.66%
2001 NZ$0.11 B163.31%
2000 NZ$45.27 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$12.73 B-4,586.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-NZ$42.07 Million-85.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-147.18%๐Ÿ‡บ๐Ÿ‡ธ USA